2023-2028 UK Cancer Diagnostics Market
2023-2028 UK Cancer Diagnostics Market--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
This unique report from provides information and analysis not available from any other published source, including 2023 supplier strategies and shares, and 2023-2028 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products by test.
The report is available by section, and can be customized to specific information needs and budget.
ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.
The companies analyzed in this report include:
- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Cepheid/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- CellSearch
- Clinical Genomics
- Decode Genetics
- DiaSorin
- Diazyme
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Epigenomics
- Erba Mannheim
- Exact Sciences
- Fujifilm Wako
- Fujirebio
- Grifols
- GSK
- Guided Therapeutics
- Hologic
- Janssen Diagnostics
- Kyowa Medex
- Labcorp
- Leica Biosystems
- Lonza
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- PerkinElmer
- Polymedco
- Qiagen
- Quest Diagnostics
- Roche
- Scienion
- Siemens Healthineers
- Takara Bio
- Theradiag
- Thermo Fisher
- Tosoh
List Of Tables
Tumor Marker Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
Insulin Tests
Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: U.K., Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
U.K., Laboratories Performing Tumor
Marker Tests by Market Segment
U.K., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Tumor Marker Tests by Annual
Test Volume
U.K., Total Tumor Marker Testing Volume
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major
Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.K., Total Tumor Marker Sales and
Market Shares Forecast
U.K., CEA Testing Market Diagnostics
Sales by Major Supplier
U.K., PSA Testing Market Diagnostics
Sales by Major Supplier
Iran Blood Typing, Grouping and Infectious Disease NAT Screening Market:2023-2028 Volume and Sales Segment Forecasts
Iran Blood Typing, Grouping and Infectious Disease NAT Screening Market:2023-2028 Volume and Sales Segment ForecastsThis unique report provides information and analysis not available from any other published source.The report is
USD 850 View ReportBolivia Blood Typing, Grouping and Infectious Disease NAT Screening Market:2023 Supplier Shares and Strategies:2023-2028 Volume and Sales Segment Forecasts
Bolivia Blood Typing, Grouping and Infectious Disease NAT Screening Market:2023 Supplier Shares and Strategies:2023-2028 Volume and Sales Segment Forecasts This unique report provides information and analysis not available from any
USD 850 View Report2023-2028 Ukraine Cancer Diagnostics Market
2023-2028 Ukraine Cancer Diagnostics Market--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers This unique report from provides information and analysis not
USD 950 View ReportUK Cancer Diagnostics Marketual Tumor Markers
This unique report from provides information and analysis not available from any other published source, including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major
USD 1850 View ReportFill The Form For Sample Request